FORMOSAN UNION CHEMICAL CORP. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.55 TWD | -0.48% |
|
+0.74% | -1.67% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 7,314 | 6,130 | 7,441 | 11,019 | 10,614 | 9,970 |
| Enterprise Value (EV) 1 | 9,493 | 8,541 | 8,763 | 12,270 | 11,702 | 11,565 |
| P/E ratio | 19.5 x | 29.5 x | 13.4 x | 11.7 x | 9.8 x | 23.8 x |
| Yield | 3.38% | 3.89% | 7.69% | 6.49% | 8.09% | 2.87% |
| Capitalization / Revenue | 0.75 x | 0.7 x | 0.88 x | 1.2 x | 1 x | 1.06 x |
| EV / Revenue | 0.97 x | 0.97 x | 1.03 x | 1.33 x | 1.11 x | 1.23 x |
| EV / EBITDA | 13.6 x | 15 x | 8.88 x | 8.41 x | 9.37 x | 17.9 x |
| EV / FCF | -10.7 x | 13.8 x | 6.89 x | 48.1 x | 17.5 x | 22.4 x |
| FCF Yield | -9.33% | 7.23% | 14.5% | 2.08% | 5.73% | 4.47% |
| Price to Book | 1.04 x | 0.89 x | 1.04 x | 1.45 x | 1.28 x | 1.25 x |
| Nbr of stocks (in thousands) | 469,451 | 477,016 | 477,016 | 477,016 | 477,016 | 477,016 |
| Reference price 2 | 15.58 | 12.85 | 15.60 | 23.10 | 22.25 | 20.90 |
| Announcement Date | 29/03/19 | 31/03/20 | 29/03/21 | 29/03/22 | 27/03/23 | 15/03/24 |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 9,785 | 8,797 | 8,482 | 9,199 | 10,571 | 9,432 |
| EBITDA 1 | 696.9 | 569.5 | 987.1 | 1,458 | 1,249 | 647.8 |
| EBIT 1 | 492.6 | 303.9 | 708.8 | 1,219 | 1,029 | 433.7 |
| Operating Margin | 5.03% | 3.45% | 8.36% | 13.25% | 9.73% | 4.6% |
| Earnings before Tax (EBT) 1 | 523.1 | 297.7 | 713.4 | 1,010 | 1,342 | 495.4 |
| Net income 1 | 380.1 | 215.3 | 554.8 | 947.6 | 1,085 | 418.2 |
| Net margin | 3.88% | 2.45% | 6.54% | 10.3% | 10.26% | 4.43% |
| EPS 2 | 0.7984 | 0.4350 | 1.160 | 1.980 | 2.270 | 0.8767 |
| Free Cash Flow 1 | -885.6 | 617.3 | 1,271 | 255.1 | 670.2 | 517.1 |
| FCF margin | -9.05% | 7.02% | 14.99% | 2.77% | 6.34% | 5.48% |
| FCF Conversion (EBITDA) | - | 108.39% | 128.79% | 17.49% | 53.67% | 79.82% |
| FCF Conversion (Net income) | - | 286.78% | 229.15% | 26.92% | 61.79% | 123.65% |
| Dividend per Share 2 | 0.5263 | 0.5000 | 1.200 | 1.500 | 1.800 | 0.6000 |
| Announcement Date | 29/03/19 | 31/03/20 | 29/03/21 | 29/03/22 | 27/03/23 | 15/03/24 |
1TWD in Million2TWD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 2,180 | 2,411 | 1,321 | 1,251 | 1,089 | 1,595 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 3.128 x | 4.234 x | 1.338 x | 0.8579 x | 0.8717 x | 2.462 x |
| Free Cash Flow 1 | -886 | 617 | 1,271 | 255 | 670 | 517 |
| ROE (net income / shareholders' equity) | 5.1% | 2.82% | 7.32% | 11.9% | 13.1% | 4.9% |
| ROA (Net income/ Total Assets) | 2.82% | 1.68% | 3.95% | 6.71% | 5.17% | 2.14% |
| Assets 1 | 13,458 | 12,798 | 14,047 | 14,125 | 20,967 | 19,564 |
| Book Value Per Share 2 | 15.00 | 14.40 | 15.00 | 16.00 | 17.30 | 16.70 |
| Cash Flow per Share 2 | 0.5400 | 0.7300 | 2.020 | 1.360 | 2.520 | 1.020 |
| Capex 1 | 560 | 209 | 128 | 112 | 86.6 | 58.4 |
| Capex / Sales | 5.72% | 2.37% | 1.51% | 1.22% | 0.82% | 0.62% |
| Announcement Date | 29/03/19 | 31/03/20 | 29/03/21 | 29/03/22 | 27/03/23 | 15/03/24 |
1TWD in Million2TWD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -1.67% | 303M | |
| -0.52% | 98.49B | |
| -10.90% | 58.77B | |
| +63.33% | 45.23B | |
| +12.56% | 37.42B | |
| -1.62% | 30.46B | |
| +7.05% | 19.26B | |
| +11.98% | 16.67B | |
| +6.45% | 13.6B | |
| -6.76% | 12.73B |
- Stock Market
- Equities
- 1709 Stock
- Financials Formosan Union Chemical Corp.